Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation
Tóm tắt
Nystatin is commonly employed to treat fungal infections in the mouth. It is not absorbed via the stomach and it will therefore not treat fungal infections in any part of the body other than the mouth. Nystatin buccoadhesive tablets release the drug very slowly due to the poor solubility of nystatin in water and also the presence of polymers with mucoadhesive properties. Therefore, the aim of the present study was to improve drug release from buccoadhesive tablets, while retaining adequate mucoadhesive properties. To this end, a solid dispersion of nystatin: lactose (1:3) was prepared and mixed with xanthan. The effects of hydrophilic surfactants such as cremophor RH40 and Tween 80 on drug release and mucoadhesive properties of nystatin tablets were also investigated as were swelling and erosion indices and strength of bioadhesion in vitro to a biological membrane. The interaction between nystatin and lactose in solid dispersion formulation was investigated by XRPD, FT-IR and DSC. The results showed that a solid dispersion formulation and mucoadhesive tablets containing surfactants led to faster drug release than their simple physical mixtures. Drug release was also faster from a solid dispersion compared to tablets containing surfactants. Swelling and erosion results showed that tablets made of a solid dispersion swelled and eroded faster than a physical mixture formulation. The presence of surfactant slightly increased the degree of swelling and erosion of buccoadhesive tablets.
Tài liệu tham khảo
Akbari, J., Nokhodchi, A., Farid, D., Adrangui, M., Siahi-Shadbad, M. R., and Saeedi, M., Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers. Farmaco, 59, 155–161 (2004).
Andersen, T., Gram-Hansen, M., Pedersen, M., and Rassing, M. R., Chewing gum as a drug delivery system for nystatin influence of solubilising agents upon the release of water insoluble drugs. Drug Dev. Ind. Pharm., 16, 1985–1994 (1990).
Berko, S., Regdon, G., Ducza, E., Falkay, G., and Ero, I., In vitro and in vivo study in rats of rectal suppositories containing furosemide. Eur. J. Pharm. Biopharm., 53, 311–315 (2002).
Chen, J. L. and Cyr, G. N., In: Manly, R. S. (Ed.), Composition producing adhesion through hydration, Adhesion in Biological System, Academic press, New York, pp. 163–181, (1970).
Choi, H. G. and Kim, C. K., Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J. Control. Release, 68, 397–404 (2000).
Codd, J. E. and Deasy, P. B., Formulation development and in vivo evaluation of a novel bioadhesive lozenge containing a synergistic combination of antifungal agents. Int. J. Pharm., 173, 13–24 (1998).
Craig, D. Q., The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm., 231, 131–144 (2002).
Desai, K. G. and Kumar, T. M., Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech, 5, Article 35 (2004).
Ford, J. L., The current status of solid dispersions. Pharm. Acta Helv., 61, 69–88 (1986).
Hiemenz, J. W. and Walsh, T. J., Lipid formulations of amphotericin B: recent progress and future directions. Clin. Infect. Dis., 22, S133-S144 (1996).
Kwon, G. S. and Yoo, B. K., Nystatin formulation having reduced toxicity. http://www.freepatentsonline.com/6413537.html.03/10/2000.
Leuner, C. and Dressman, J., Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm., 50, 47–60 (2000)
Llabot, J. M., Manzo, R. H., and Allemandi, D. A., Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int. J. Pharm., 276, 59–66 (2004).
Millns, B. and Martin, M. V., Nystatin pastilles and suspension in the treatment of oral candidosis. Br. Dent. J., 181, 209–211 (1996).
Papadopoulou, V., Kosmidis, K., Vlachou, M., and Macheras, P., On the use of the Weibull function for the discernment of drug release mechanisms. Int. J. Pharm., 309 44–50 (2006).
Peppas, N. A., Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv., 60, 110–111 (1985).
Pons, V., Greenspan, D., Lozada, N. F., McPhail, L., Gallant, J. E., Tunkel, A., Johnson, C. C., McCarty, J., Panzer, H., Levenstein, M., Barranco, A., and Green, S., Oropharyugeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clin. Infect. Dis., 24, 1204–1207 (1997).
Ritger, P. L. and Peppas, N. A., A simple equation for description of solute release, II. Fickian and anomalous release from swellable devices. J. Control. Release, 5, 37–42 (1987).
Sakeer, K., Al-Zein, H., Hassan, I., Martin, G. P., and Nokhodchi, A., Use of a natural occurring polymer and its binary blends with synthetic polymers to design controlled release formulations of buccoadhesive nystatin tablets. Pharm. Dev. Technol., 15, 360–368 (2010).
Sriamornsak, P., Thirawong, N., and Korkerd, K., Swelling, erosion and release behavior of alginate-based matrix tablets. Eur. J. Pharm. Biopharm., 66, 435–450 (2007).
Tallury, P., Randall, K. M., Khin, L. T., John, S. P., and Kalachandra, S., Effects of solubilizing surfactants and loading of antiviral, antimicrobial, and antifungal drugs on their release rates from ethylene vinyl acetate copolymer. Dent. Mater., 23, 977–982 (2007).
Wong, C. F., Yuen, K. H., and Peh, K. K., An in-vitro method for buccal adhesion studies: importance of instrument variables. Int. J. Pharm., 180, 47–57 (1999).